What is Medivolve?
Founded in 2005, Medivolve operates at the intersection of digital health innovation and clinical service delivery. By leveraging advanced technology to streamline healthcare workflows, the company has established itself as a critical infrastructure provider within the Canadian medical landscape. Its market position is defined by a focus on high-efficiency service models that address the evolving needs of modern healthcare systems. Through its strategic deployment of capital, Medivolve continues to refine its service offerings, ensuring that its technological framework remains at the forefront of the industry's digital transformation.
How much funding has Medivolve raised?
Medivolve has raised a total of $16.9M across 3 funding rounds:
Share Placement
$12M
Share Placement
$887K
Share Placement
$4M
Share Placement (2021): $12M, investors not publicly disclosed
Share Placement (2022): $887K, investors not publicly disclosed
Share Placement (2023): $4M, investors not publicly disclosed
Key Investors in Medivolve
Undisclosed Investors
Undisclosed Investors
Undisclosed Investors
What's next for Medivolve?
With the infusion of this recent capital, Medivolve is well-positioned to accelerate its enterprise-level initiatives and deepen its market penetration. The company's strategic roadmap likely involves scaling its core service platforms and potentially exploring new technological integrations to enhance patient outcomes and operational throughput. As the healthcare sector continues to prioritize digital agility, Medivolve's ability to secure substantial financing signals strong investor confidence in its long-term viability and its capacity to navigate the complexities of the healthcare technology market. Future growth will likely be characterized by sustained investment in R&D and the expansion of its service footprint across key regional markets.
See full Medivolve company page
